News for hackers. Stuff that matters.
Re:AlphaFold at CASP13: What just happened? by dnautics on Monday December 10, 2018 @06:08AM (#18646986)
Why should they invest in r&d when someone like alphabet will do it for them?
Re:AlphaFold at CASP13: What just happened? by melling on Monday December 10, 2018 @06:40AM (#18647128)
I believe they do spend a lot of money on R&D. Someone came along with a new idea and applied it to their field.

Now that Alphabet has sown them a better way, money should pour into the new technique.

Re:AlphaFold at CASP13: What just happened? by dnautics on Monday December 10, 2018 @01:28PM (#18650018)
While big pharma does do internal r&d, de facto, new drugs and drug strategies largely come by letting the government fund researchers (typically professors at large research institutes), encouraging these professors to do a spin-off (I deliberately don't want to use "startup") to absorb the scientific risk, followed by an acquisition for IP.